The use of Tocilizumab in COVID-19 critically ill patients with renal impairment: a multicenter, cohort study von Aljuhani, Ohoud, Al Sulaiman, Khalid, B Korayem, Ghazwa, Alharbi, Aisha, Altebainawi, Ali F, Aldkheel, Shatha A, Alotaibi, Sarah G, Vishwakarma, Ramesh, Alshareef, Hanan, Alsohimi, Samiah, AlFaifi, Mashael, Al Shaya, Abdulrahman, Alhaidal, Haifa A, Alsubaie, Raghad M, Alrashidi, Hessah, Albarqi, Khalid J, Alangari, Dalal T, Alanazi, Reem M, Altaher, Noora M, Al-Dorzi, Hasan M

Volltext

The use of Tocilizumab in COVID-19 critically ill patients with renal impairment: a multicenter, cohort study von Aljuhani, Ohoud, Al Sulaiman, Khalid, Korayem, Ghazwa B, Alharbi, Aisha, Altebainawi, Ali F., Aldkheel, Shatha A., Alotaibi, Sarah G., Vishwakarma, Ramesh, Alshareef, Hanan, Alsohimi, Samiah, AlFaifi, Mashael, Al Shaya, Abdulrahman, Alhaidal, Haifa A., Alsubaie, Raghad M., Alrashidi, Hessah, Albarqi, Khalid J., Alangari, Dalal T., Alanazi, Reem M., Altaher, Noora M., Al-Dorzi, Hasan M.

Volltext bestellen

Doxycycline’s Potential Role in Reducing Thrombosis and Mortality in Critically Ill Patients With COVID-19: A Multicenter Cohort Study von Al Sulaiman, Khalid, Aljuhani, Ohoud, Korayem, Ghazwa B., Alnajjar, Lina I., Altebainawi, Ali F., AlFaifi, Mashael, Vishwakarma, Ramesh, Alenazi, Abeer A., Alalawi, Mai, Alissa, Abdulrahman, Alsowaida, Yazed S., Alsohimi, Samiah, Almagthali, Alaa, Alay, Saeed M., Altaher, Noora, Alamri, Mohammed G., Alangari, Dalal, Alzahrani, Amer, Abdul Razack, Habeeb Ibrahim, Alhamoud, Jwael, Alshaya, Abdulrahman, Gramish, Jawaher, Al Aamer, Kholoud, Alsaeedi, Alawi S., Alghamdi, Ghassan

Volltext